Larimar Therapeutics (LRMR) Change in Accured Expenses (2013 - 2025)
Larimar Therapeutics (LRMR) reported Change in Accured Expenses of $25.76 million for Q4 2025, up 252.9% from $7.3 million a year earlier and up 127.7% from the prior quarter.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Change in Accured Expenses (2013 - 2025) Analysis & Trends
For FY2025, Larimar Therapeutics posted Change in Accured Expenses of $37.55 million, up 179.5% from FY2024.
- Change in Accured Expenses has a five-year compound annual growth rate of 63.3% (FY2020 to FY2025).
- By year, Change in Accured Expenses came in at $13.44 million in FY2024, -$1.02 million in FY2023, $1.82 million in FY2022 (+142.5%) and $749,000 in FY2021 (-76.8%).
- The Q4 2025 figure ranks as the highest quarterly Change in Accured Expenses in data going back to Q3 2013.
- The high point for year-over-year Change in Accured Expenses in five years was Q4 2025 (growth of 252.9%); the low point was Q2 2025 (a decline of 63.4%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $11.31 million (Q3 2025), $2.6 million (Q2 2025) and -$2.12 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Larimar Therapeutics | 307.49 Mn | -299.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 25.76 Mn |
| Sep 30, 2025 | 11.31 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Dec 31, 2024 | 7.30 Mn |
| Sep 30, 2024 | -3.63 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Sep 30, 2023 | 729,000.00 |
| Jun 30, 2023 | -2.36 Mn |
| Mar 31, 2023 | -1.68 Mn |
| Dec 31, 2022 | 719,000.00 |
| Sep 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 816,000.00 |
| Mar 31, 2022 | -752,000.00 |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | 2.29 Mn |
| Jun 30, 2021 | 1.06 Mn |
| Mar 31, 2021 | -1.23 Mn |
API Access
Larimar Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();